Rapacuronium bromide (Raplon®, Organon) is a rapidly acting, non-depolarizing neuromuscular blocker used in modern anaesthesia, to aid and enable endotracheal intubation, which is often necessary to assist in the controlled ventilation of unconscious patients during surgery and sometimes in intensive care. As a non-depolarizing agent, it does not cause initial stimulation of muscles before weakening them.

Due to risk of fatal bronchospasm, it was withdrawn from the United States market by the manufacturer on March 27, 2001.

More on [ Rapacuronium ]

Rapacuronium - Twitter Search

Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors ... - http://bit.ly/79g3Og - RT
MediaTower (Media Tower) Mon, 28 Dec 2009 18:43:41 -0000
Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors ... - http://bit.ly/79g3Og - RT
Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors: Background: M.. http://bit.ly/6a7yte
zampbioworld (zampbioworld) Mon, 28 Dec 2009 18:27:13 -0000
Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors: Background: M.. http://bit.ly/6a7yte
Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors ... - http://bit.ly/79g3Og
WorldNewsEU (News Stories) Mon, 28 Dec 2009 16:38:52 -0000
Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors ... - http://bit.ly/79g3Og

Subscribe to Rapacuronium RSS feed